Solving the Translational Drug Development Gap, from Fibrotic Mechanisms to Clinically Successful Therapeutics
The summit focuses on solving the translational drug development gap, from fibrotic mechanisms to clinically successful therapeutics.
Dr. Morten Asser Karsdal, CEO of Nordic Bioscience A/S, will be presenting his topic “Extracellular Matrix Remodeling is the Common Denominator in all Fibrotic Diseases“ at the event. Tune in on 2 November, 11.30 EST / 8.30 PST.
Amongst other insights, Dr. Karsdal will talk about:
Fibroblast and the importance in fibro-inflammatory disorders and the quantification thereof
Assessing ECM remodeling non-invasively can be used as prognostic and pharmacodynamic biomarkers
FACIT collagens: what are they and why are they important?
Nordic Bioscience is a proud sponsor of the 5th Annual Drug Development Summit.
